Life sciences technology solutions company MedNet Solutions has released its new eClinical technology iMedNet EDC.
The program allows non-technical research personnel build and manage their own clinical studies.
It includes the capability to create new studies in seconds using existing ones, and guidance in the study build process.
Now MedNet president John Robertson says the software will revolutionize clinical trials.
He said: “iMedNet EDC is truly a game-changing eClinical technology platform.
“It provides the entire life sciences market with an EDC/CTMS solution that is incredibly flexible and easy to use, completely configurable by sponsor and CRO staff, and extremely affordable.
“This means that, with iMedNet, EDC is now both practical and economically viable for any study, even very small studies of short duration."
Max Neeman has launched its customized Project Management Software (PMS).
The business say its software is tailored for each individual study, and is unique because of extended features in regulatory, site initiation, and CDMS.
A spokesperson for the company said: “These help clients track the progress of the study in terms of enrollment status, regulatory and EC status, monitoring visits, CRF retrieval status and safety reporting – at their convenience and from anywhere.
“Also additional observation can be added for a module according to the study needs. Thus it is a flexible management solution, which enables any kind of sharing of Web-based information free of cost.”
Clinovo has launched ClinDesk, a full-service electronic data capture (EDC) help desk system providing technical support for all major EDC systems used by biotechs, medical device and pharmaceutical companies.
Its spectrum of clinical trial program know-how includes InForm, MedNet, Medidata Rave, Oracle RDC, OpenClinica, and ClinCapture, Clinovo's open source EDC platform.
And Clinovo says it is the first platform to include support for all major EDC systems used in clinical trials.
Marc Desgrousilliers, VP of technical operations for the firm, said: "We understand the importance of providing timely assistance to clinical trial sites.
“To remain competitive, it is essential for sponsors to get impeccable EDC support from their provider."
StudyManager’s Evolve software product sales have increased by more than 500 per cent year-on-year.
The company attributed the boom in sales for its EDC and CTMS (clinical trial management software) system down to increased pressure to reduce technology costs for eClinical solutions within the life sciences industry.
A demand for easy-to-implement eClinical solutions as well as a growing awareness of their product were also key factors in the rise in trade, according to the firm.
"2011 has been somewhat of a watershed event for our company,” said Bruce Schatzman, CEO of StudyManager.
“Not only has the growth been beyond our expectations, it has sustained itself and helps set the stage for breakout growth in the future.”
ClinPlus providers DZS Software Solutions has announced plans to unveil several new products at the the annual Society for Clinical Data Management (SCDM) event.
The New Jersey-based company will showcase its developments – named ClinPlus CTMS 2.0 – the results of a three year effort to deliver a more flexible, lower cost alternative solution to larger EDC systems.
A spokesperson for the company said: “The software offers simplified delivery under a new SaaS subscription model in addition to traditional installed and 3rd party hosted delivery options.
“ClinPlus CTMS 2.0 offers enhanced functionality with site visit report authoring and review workflow, automated email notification of events and alerts, scheduled report execution with email delivery, enhanced EDC integration and improved data importing capabilities.”
SCDM takes place September 11-14 in Baltimore, Maryland.
Johnson and Johnson Vision Care (JJVC) has achieved its three-year EDC efficiency plans in less than one year, using BioClinica Express EDC.
JJVC now has the capability to run paperless clinical studies, by entering data directly, while streamlining the study build process, using Express EDC.
Brian Schwam, MD and director of clinical affairs and ocular sciences at JJVC said: “Our partnership with BioClinica has helped JJVC significantly improve its clinical trial efficiency in a relatively short period of time.
“JJVC now receives clean data ready for analysis in a matter of a few weeks after last patient out (LPO), which allows us to make decisions based on clinical data faster.”